⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17761661 | 0.94 | — | — | |
| SCHEMBL4608955 | 0.94 | — | — | |
| SCHEMBL12723987 | 0.94 | — | — | |
| SCHEMBL5374330 | 0.94 | — | — | |
| SCHEMBL15958873 | 0.94 | — | — | |
| SCHEMBL3295943 | 0.94 | — | — | |
| SCHEMBL4865350 | 0.88 | — | — | |
| SCHEMBL4868112 | 0.88 | — | — | |
| SCHEMBL9419750 | 0.88 | — | — | |
| SCHEMBL6064795 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528713-A | Synthesis method of nemonoxacin intermediate 2, 4-difluoro-3-methoxy-1-benzoic acid | 浙江昌海制药有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119528713-A | Synthesis method of nemonoxacin intermediate 2, 4-difluoro-3-methoxy-1-benzoic acid | 浙江昌海制药有限公司 | 2025-02-28 | — | — | CN | disclosed |
| EP-3167396-B1 | IMMUNE RECOGNITION MOTIFS | IOGENETICS LLC (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20230332334-A1 | LIQUID CRYSTAL POLYESTER FIBERS AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2023-10-19 | — | — | US | disclosed |
| US-11572508-B2 | Non-linear surfactant | POWDERMET, INC. (US) | 2023-02-07 | — | — | US | disclosed |
| US-20220127534-A1 | NON-LINEAR SURFACTANT | POWDERMET, INC. | 2022-04-28 | — | — | US | disclosed |
| US-11273422-B2 | Non-linear surfactant | POWDERMET, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| US-20210237013-A1 | NON-LINEAR SURFACTANT | POWDERMET, INC. | 2021-08-05 | — | — | US | disclosed |
| US-20170362338-A1 | GLYCAN-BASED ANTIBODY-DRUG CONJUGATES | MERCK SHARP & DOHME CORP. (US) | 2017-12-21 | — | — | US | disclosed |
| US-9782236-B2 | Method and system for finding tooth features on a virtual three-dimensional model | ORAMETRIX, INC. (US) | 2017-10-10 | — | — | US | disclosed |
| US-7001601-B1 | Ganglioside-KLH conjugate vaccine plus QS-21 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2006-02-21 | — | — | US | disclosed |
| US-6967022-B1 | Ganglioside-KLH conjugate vaccines plus QS-21 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2005-11-22 | — | — | US | disclosed |
| US-6936253-B1 | Ganglioside-KLH conjugate vaccines plus QS-21 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2005-08-30 | — | — | US | disclosed |
| US-6916476-B1 | Ganglioslide-KLH conjugate vaccine plus QS-21 | SLOAN-KETTERING INSTITUTE FOR CANCER INSTITUTE (US) | 2005-07-12 | — | — | US | disclosed |
| EP-1360963-A2 | Ganglioside-KLH conjugate vaccines with QS-21 | Sloan-Kettering Institute For Cancer Research (US) | 2003-11-12 | — | — | EP | disclosed |
| EP-0680338-B1 | GANGLIOSIDE-KLH CONJUGATE VACCINES WITH QS-21 | SLOAN KETTERING INST CANCER (US) | 2003-04-16 | — | — | EP | disclosed |
| EP-0680338-A4 | GANGLIOSIDE-KLH CONJUGATE VACCINES WITH QS-21. | SLOAN KETTERING INST CANCER (US) | 1997-04-09 | — | — | EP | disclosed |
| EP-0684261-A2 | Emulsion polymerisation inhibitor and suspension polymerisation method using the agent | NIPPON SHOKUBAI CO., LTD. (JP) | 1995-11-29 | — | — | EP | disclosed |
| EP-0680338-A1 | GANGLIOSIDE-KLH CONJUGATE VACCINES WITH QS-21 | Sloan-Kettering Institute For Cancer Research (US) | 1995-11-08 | — | — | EP | disclosed |
| WO-1994016731-A1 | GANGLIOSIDE-KLH CONJUGATE VACCINES WITH QS-21 | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1994-08-04 | — | — | WO | disclosed |